PFS Investments’s Gilead Sciences GILD Stock Holding History

PFS Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$48.7M	Buy	632,028 +28,124	+5%	+$2.24M	0.8%	27
2023 Q1	$50.3M	Buy	603,904 +61,276	+11%	+$5.08M	0.87%	27
2022 Q4	$46.6M	Buy	542,628 +57,975	+12%	+$4.59M	0.87%	25
2022 Q3	$29.9M	Buy	484,653 +128,688	+36%	+$8.11M	0.54%	38
2022 Q2	$22M	Buy	355,965 +61,439	+21%	+$3.8M	0.44%	71
2022 Q1	$17.5M	Buy	294,526 +42,683	+17%	+$2.73M	0.33%	84
2021 Q4	$18.3M	Buy	251,843 +82,587	+49%	+$5.69M	0.35%	79
2021 Q3	$11.2M	Buy	169,256 +16,493	+11%	+$1.16M	0.23%	105
2021 Q2	$10.4M	Buy	152,763 +73,700	+93%	+$4.92M	0.24%	111
2021 Q1	$5.11M	Buy	79,063 +9,924	+14%	+$640K	0.13%	148
2020 Q4	$4.32M	Buy	69,139 +6,353	+10%	+$383K	0.12%	152
2020 Q3	$3.97M	Buy	62,786 +7,305	+13%	+$507K	0.13%	146
2020 Q2	$4.27M	Buy	55,481 +9,381	+20%	+$719K	0.16%	121
2020 Q1	$3.45M	Buy	+46,100	New	+$3.19M	0.15%	108

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFS Investments's GILD Position: Q2 2023 in Review

PFS Investments increased its Gilead Sciences (GILD) stake by 4.7% in Q2 2023, buying an estimated $2.24M and bringing the position to 632,028 shares worth $48.7M. The position accounts for 0.8% of the portfolio, ranked #27.

PFS Investments first reported a position in GILD in Q1 2020 and has held it in 14 quarters since. The position peaked at $50.3M in Q1 2023. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

PFS Investments held 632,028 shares of Gilead Sciences worth $48.7M as of Q2 2023.
PFS Investments bought 28,124 Gilead Sciences shares in Q2 2023, an estimated $2.24M.
Gilead Sciences made up 0.8% of PFS Investments's portfolio in Q2 2023, its #27 holding.
PFS Investments first reported a position in Gilead Sciences in Q1 2020 and has held it in 14 quarters since.
PFS Investments's Gilead Sciences position peaked at $50.3M in Q1 2023.
1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.